1. Home
  2. FSBW vs ENGN Comparison

FSBW vs ENGN Comparison

Compare FSBW & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$39.25

Market Cap

312.1M

Sector

Finance

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$7.00

Market Cap

647.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
ENGN
Founded
1936
1999
Country
United States
Canada
Employees
537
82
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
312.1M
647.1M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
FSBW
ENGN
Price
$39.25
$7.00
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$46.00
$21.00
AVG Volume (30 Days)
7.3K
431.4K
Earning Date
04-22-2026
01-01-0001
Dividend Yield
2.96%
N/A
EPS Growth
N/A
N/A
EPS
3.18
N/A
Revenue
$4,612,000.00
N/A
Revenue This Year
$14.94
N/A
Revenue Next Year
$10.47
N/A
P/E Ratio
$12.34
N/A
Revenue Growth
44.80
N/A
52 Week Low
$34.61
$2.66
52 Week High
$44.22
$12.25

Technical Indicators

Market Signals
Indicator
FSBW
ENGN
Relative Strength Index (RSI) 34.09 32.11
Support Level $37.41 $6.03
Resistance Level $40.79 $7.33
Average True Range (ATR) 1.10 0.63
MACD -0.18 -0.33
Stochastic Oscillator 18.97 10.70

Price Performance

Historical Comparison
FSBW
ENGN

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: